Duloxetine Hydrochloride Enteric Tablets 盐酸度洛西汀肠溶片 ; 度洛西汀肠溶片
Aspirin Enteric Tablets 阿司匹林肠溶片
Mesalazine Enteric-coated Tablets 美沙拉秦肠溶片
Omeprazole Enteric-coated Tablets 奥美拉唑肠溶片 ; 产品
Thymopeptides Enteric-coated Tablets 胸腺肽肠溶片
Diclofenac Sodium Enteric-coated Tablets 双氯芬酸钠肠溶片 ; 产品
Mycophenolate Sodium Enteric-coated Tablets 麦考酚钠肠溶片
Erythromycin Enteric-coated Tablets 红霉素肠溶片 ; 红霉素片
enteric-coated tablets 肠溶片 ; 溶菌酶肠溶片 ; 美沙拉秦肠溶片
Indomethacin enteric dispersible tablets were prepared, and factors affected disintegration time and dissolution rate were studied.
制备了吲哚美辛肠溶分散片，考察辅料对其崩解时限及溶出速度的影响。
OBJECTIVE To prepare the 5 aminosalicylic acid (5 ASA) enteric time controlled released tablets with site specific drug delivery in colon.
目的制备5氨基水杨酸(5 ASA)肠溶包衣片，使药物在结肠释放。
CONCLUSION 5 ASA Enteric time controlled released tablets can be prepared by using adequate core and coating.
结论采用合适的片芯和包衣，可制备5氨基水杨酸肠溶定时释放片。
应用推荐